Suivre
C. Michael Gibson, M.D.
C. Michael Gibson, M.D.
Harvard Medical School
Adresse e-mail validée de bidmc.harvard.edu - Page d'accueil
Titre
Citée par
Citée par
Année
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
31825*2014
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
28778*2016
Prasugrel versus clopidogrel in patients with acute coronary syndromes
SD Wiviott, E Braunwald, CH McCabe, G Montalescot, W Ruzyllo, ...
New England Journal of Medicine 357 (20), 2001-2015, 2007
83562007
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ...
Circulation 123 (23), 2736-2747, 2011
45062011
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
34652020
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
New England Journal of Medicine 352 (12), 1179-1189, 2005
29342005
TIMI frame count: a quantitative method of assessing coronary artery flow
CM Gibson, CP Cannon, WL Daley, JT Dodge Jr, B Alexander, SJ Marble, ...
Circulation 93 (5), 879-888, 1996
27141996
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
CP Cannon, WS Weintraub, LA Demopoulos, R Vicari, MJ Frey, N Lakkis, ...
New England Journal of Medicine 344 (25), 1879-1887, 2001
26022001
Rivaroxaban in patients with a recent acute coronary syndrome
JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ...
New England Journal of Medicine 366 (1), 9-19, 2012
25102012
Prevention of bleeding in patients with atrial fibrillation undergoing PCI
CM Gibson, R Mehran, C Bode, J Halperin, FW Verheugt, P Wildgoose, ...
New England Journal of Medicine 375 (25), 2423-2434, 2016
17392016
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
CP Cannon, CM Gibson, CT Lambrew, DA Shoultz, D Levy, WJ French, ...
Jama 283 (22), 2941-2947, 2000
16432000
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised …
G Montalescot, SD Wiviott, E Braunwald, SA Murphy, CM Gibson, ...
The Lancet 373 (9665), 723-731, 2009
14062009
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
TD Henry, BH Annex, GR McKendall, MA Azrin, JJ Lopez, FJ Giordano, ...
Circulation 107 (10), 1359-1365, 2003
13862003
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
CM Gibson, CP Cannon, SA Murphy, KA Ryan, R Mesley, SJ Marble, ...
Circulation 101 (2), 125-130, 2000
12432000
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
MS Sabatine, DA Morrow, JA de Lemos, CM Gibson, SA Murphy, N Rifai, ...
Circulation 105 (15), 1760-1763, 2002
10532002
Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial
EM Antman, RP Giugliano, CM Gibson, CH McCabe, P Coussement, ...
Circulation 99 (21), 2720-2732, 1999
10041999
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy
RH Chan, BJ Maron, I Olivotto, MJ Pencina, GE Assenza, T Haas, ...
Circulation 130 (6), 484-495, 2014
9842014
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study
MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ...
Jama 294 (10), 1224-1232, 2005
9812005
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk
P Urban, R Mehran, R Colleran, DJ Angiolillo, RA Byrne, D Capodanno, ...
Circulation 140 (3), 240-261, 2019
9742019
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...
New England Journal of Medicine 375 (12), 1131-1141, 2016
9612016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20